Bioinformatics and Experimental Validation for Identifying Biomarkers Associated with AMG510 (Sotorasib) Resistance in KRASG12C-Mutated Lung Adenocarcinoma
International Journal of Molecular Sciences · 26.01.2024 · 25 (3) · 1555
DOI: 10.3390/ijms25031555 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.01.2024. Verfasst von Peng Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Marine Drugs, Laboratory for Marine Drugs and Bioproducts of Qingdao National Laboratory for Marine Science and Technology, Chinese…. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms, F-Box Proteins, Piperazines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hainan Provincial Joint Project of Sanya Yazhou Bay Science and Technology City, Shandong Provincial Natural Science Foundation.
Abstract (Originalsprache)
The Kirsten rat sarcoma viral oncogene homolog (KRAS)G12C mutation is prevalent in lung adenocarcinoma (LUAD), driving tumor progression and indicating a poor prognosis. While the FDA-approved AMG510 (Sotorasib) initially demonstrated efficacy in treating KRASG12C-mutated LUAD, resistance emerged within months. Data from AMG510 treatment-resistant LUAD (GSE204753) and single-cell datasets (GSE149655) were analyzed. Gene set variation analysis (GSVA) and gene set enrichment analysis (GSEA) were used to explore enriched signaling pathways, nomogram models were constructed, and transcription factors predicting resistance biomarkers were predicted. CIBERSORT identified immune cell subpopulations, and their association with resistance biomarkers was assessed through single-cell analysis. AMG510-resistant LUAD cells (H358-AR) were constructed, and proliferative changes were evaluated using a CCK-8 assay. Key molecules for AMG510 resistance, including SLC2A1, TLE1, FAM83A, HMGA2, FBXO44, and MTRNR2L12, were recognized. These molecules impacted multiple signaling pathways and the tumor microenvironment and were co-regulated by various transcription factors. Single-cell analysis revealed a dampening effect on immune cell function, with associations with programmed cell death ligand 1 (PDL1) expression, cytokine factors, and failure factors. The findings indicate that these newly identified biomarkers are linked to the abnormal expression of PDL1 and have the potential to induce resistance through immunosuppression. These results highlight the need for further research and therapeutic intervention to address this issue effectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Marine Drugs, Laboratory for Marine Drugs and Bioproducts of Qingdao National Laboratory for Marine Science and Technology, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean Univers…
- Faculty of Information Science and Engineering, Ocean University of China, Qingdao 266003, China.
ORCID-Profile: Peng Lin
Förderung
- Hainan Provincial Joint Project of Sanya Yazhou Bay Science and Technology City
- Shandong Provincial Natural Science Foundation
Zitieren
APA
Lin, P., Cheng, W., Qi, X., Zhang, P., Xiong, J., & Li, J. (2024). Bioinformatics and Experimental Validation for Identifying Biomarkers Associated with AMG510 (Sotorasib) Resistance in KRASG12C-Mutated Lung Adenocarcinoma. International Journal of Molecular Sciences, 25(3), 1555. https://doi.org/10.3390/ijms25031555
Vancouver
Lin P, Cheng W, Qi X, Zhang P, Xiong J, Li J. Bioinformatics and Experimental Validation for Identifying Biomarkers Associated with AMG510 (Sotorasib) Resistance in KRASG12C-Mutated Lung Adenocarcinoma. International Journal of Molecular Sciences. 2024;25(3):1555. doi:10.3390/ijms25031555
BibTeX
@article{Lin2024,
author = {Lin, Peng and Cheng, Wei and Qi, Xin and Zhang, Pinglu and Xiong, Jianshe and Li, Jing},
title = {Bioinformatics and Experimental Validation for Identifying Biomarkers Associated with AMG510 (Sotorasib) Resistance in KRASG12C-Mutated Lung Adenocarcinoma},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {3},
pages = {1555},
doi = {10.3390/ijms25031555}
}
EUVIMED